| A Multistage Rigid-Affine-Deformable Network for
Three-Dimensional Multimodal Medical Image Registration | | | Journal | 2023 | 10.3390/app132413298 | CRISP | 22433 | Secondary Research |
| Automated Prognosis of Renal Function Decline in ADPKD Patients using Deep Learning | 37612178 | | Journal | 2023 | 10.1016/j.zemedi.2023.08.001 | CRISP | 22433 | Secondary Research |
| Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. | 18818683 | PMC2756756 | Journal | 2008 | 10.1038/ki.2008.485 | CRISP | | Contributing Study |
| Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD | 31922066 | PMC6943786 | Journal | 2019 | https://doi.org/10.1016/j.ekir.2019.09.004 | CRISP | 21391 | Secondary Research |
| Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort. | 16452494 | | Journal | 2006 | 10.1681/ASN.2005070697 | CRISP | | Contributing Study |
| Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. | 17582161 | | Journal | 2007 | 10.1681/ASN.2006121387 | CRISP | | Contributing Study |
| Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. | 17035604 | | Journal | 2006 | 10.1681/ASN.2006080835 | CRISP | | Contributing Study |
| Deep Learning based automated Prognosis of Renal Function Decline in ADPKD: initial results | | | Journal | 2023 | | CRISP | 22433 | Secondary Research |
| Deep Learning-Based Total Kidney Volume Segmentation in Autosomal Dominant Polycystic Kidney Disease Using Attention, Cosine Loss, and Sharpness Aware Minimization | 35626314 | PMC9139731 | Journal | 2022 | 10.3390/diagnostics12051159 | CRISP | 22433 | Secondary Research |
| Development of a Clinical Trial Enrichment (CTE) Tool for Autosomal Dominant Polycystic Kidney Disease | | | Conference Presentation | 2023 | | HALT PKD, CRISP | 22905 | Secondary Research |
| Effects of Tolvaptan on Kidney Function Decline in Patients Aged >55 Years With Autosomal Dominant Polycystic Kidney Disease: Pooled Data Analysis | 37250503 | PMC10220412 | Journal | 2023 | 10.1016/j.xkme.2023.100639 | HALT PKD, CRISP | 21540 | Secondary Research |
| Enhancing individual glomerular filtration rate assessment: can we trust the equation? | https://pubmed.ncbi.nlm.nih.gov/39885391/ | | Journal | 2025 | 10.1186/s12882-025-03972-0 | MDRD, PERL, DCCT/EDIC, AASK Trial, ALTOLD, AASK Cohort, CRIC, CRISP | 23649 | Secondary Research |
| Estimating glomerular filtration in young people | 39314869 | | Journal | 2024 | https:/doi.org/10.1093/ckj/sfae261 | MDRD, PERL, AASK Trial, DCCT/EDIC, AASK Cohort, CRISP, CRIC, ALTOLD | 23649 | Secondary Research |
| Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease. | 31088850 | PMC6556721 | Journal | 2019 | 10.2215/CJN.10360818 | CRISP | 20790 | Secondary Research |
| Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. | 28532709 | PMC5651185 | Journal | 2017 | 10.1016/j.kint.2017.03.026 | CRISP | 20790 | Secondary Research |
| KIDNEY FUNCTION DECLINE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS: ASSESSMENT OF TOLVAPTAN'S REAL WORLD EFFECTIVENESS | | | Conference Presentation | 2023 | | HALT PKD, CRISP | 21540 | Secondary Research |
| Ketosis ameliorates renal cyst growth in polycystic kidney disease | 31631001 | PMC6904245 | Journal | 2019 | 10.1016/j.cmet.2019.09.012 | CRISP | 21992 | Secondary Research |
| Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. | 17699192 | | Journal | 2006 | 10.2215/CJN.00080605 | CRISP | | Contributing Study |
| Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. | 17699395 | | Journal | 2007 | 10.2215/CJN.00910306 | CRISP | | Contributing Study |
| Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. | 14633145 | | Journal | 2003 | 10.1046/j.1523-1755.2003.00326.x | CRISP | | Contributing Study |
| Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease | 29706351 | PMC5986722 | Journal | 2018 | 10.1016/j.ajhg.2018.03.013 | CRISP | 21391 | Secondary Research |
| POOLED DATA ANALYSIS OF THE EFFECT OF TOLVAPTAN IN PATIENTS AGED 18-35 YEARS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE | 35570988 | PMC9091612 | Conference Presentation | 2023 | 10.1016/j.ekir.2022.02.009 | HALT PKD, CRISP | 21540 | Secondary Research |
| Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease. | 28027795 | PMC5497695 | Journal | 2017 | 10.1053/j.ajkd.2016.10.021 | CRISP | 20790 | Secondary Research |
| Performance of the European Kidney Function Consortium (EKFC) creatinine-based equation in American cohorts | 38101514 | | Journal | 2023 | 10.1016/j.kint.2023.11.024 | AASK Trial, MDRD, DCCT/EDIC, PERL, ALTOLD, CRISP, CRIC, AASK Cohort | 23649 | Secondary Research |
| Pooled Data Analysis of the Long-Term Treatment Effects of Tolvaptan in ADPKD | 35570988 | PMC9091612 | Journal | 2022 | 10.1016/j.ekir.2022.02.009 | CRISP | 21540 | Secondary Research |
| Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. | 30591038 | PMC6307167 | Journal | 2018 | 10.1186/s12882-018-1182-0 | CRISP | 20790 | Secondary Research |
| Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. | 12911554 | | Journal | 2003 | 10.1046/j.1523-1755.2003.00185.x | CRISP | | Contributing Study |
| Soluble Urokinase Plasminogen Activator Receptor
and Decline in Kidney Function in Autosomal Dominant
Polycystic Kidney Disease | 31171572 | | Journal | 2019 | 10.1681/ASN.2018121227 | CRISP | 21643 | Secondary Research |
| Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease | 31171572 | PMC6622421 | Journal | 2019 | 10.1681/ASN.2018121227 | CRISP | 21643 | Secondary Research |
| Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). | 16310571 | | Journal | 2005 | 10.1053/j.ajkd.2005.08.026 | CRISP | | Contributing Study |
| Volume progression in polycystic kidney disease. | 16707749 | | Journal | 2006 | 10.1056/NEJMoa054341 | CRISP, CRIC | | Contributing Study |
